Tumor Lysis Rate
97.5%
Primed CD8+ T-Cells
340
Viable Melanoma Cells
3 / 120
Clinical Clearance Day
Day 18
mRNA Lipid Nanoparticles
Dendritic Cell (MHC-I Presentation)
Primed CD8+ CTLs
Melanoma (Stage IIIc)
Anti-PD-1 Checkpoint Blockade